Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study).

Autor: Maki Ishii, Ikuko Hirai, Keiji Tanese, Takayuki Fusumae, Yoshio Nakamura, Keitaro Fukuda, Hiroshi Uchi, Kenji Kabashima, Atsushi Otsuka, Kenji Yokota, Naoya Yamazaki, Kenjiro Namikawa, Taku Fujimura, Tatsuya Takenouchi, Yuki Yamamoto, Mana Nishiguchi, Yasunori Sato, Masayuki Amagai, Takeru Funakoshi, Ishii, Maki
Zdroj: Medicine; 10/30/2020, Vol. 99 Issue 44, p1-6, 6p
Databáze: Complementary Index